NAVIDEA BIOPHARMACEUTICALS I's ticker is and the CUSIP is 63937X902. A total of 1 filers reported holding NAVIDEA BIOPHARMACEUTICALS I in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $0 | -100.0% | 1,000 | -82.5% | 0.00% | – |
| Q4 2022 | $1 | -100.0% | 5,700 | -75.2% | 0.00% | – |
| Q3 2022 | $5,000 | -64.3% | 23,000 | +16.2% | 0.00% | – |
| Q2 2022 | $14,000 | -22.2% | 19,800 | -17.2% | 0.00% | – |
| Q1 2022 | $18,000 | -43.8% | 23,900 | -25.5% | 0.00% | – |
| Q4 2021 | $32,000 | -65.2% | 32,100 | -37.4% | 0.00% | – |
| Q3 2021 | $92,000 | -1.1% | 51,300 | 0.0% | 0.00% | – |
| Q2 2021 | $93,000 | -30.6% | 51,300 | +7602.7% | 0.00% | – |
| Q1 2021 | $134,000 | +415.4% | 666 | +441.5% | 0.00% | – |
| Q4 2020 | $26,000 | +188.9% | 123 | +232.4% | 0.00% | – |
| Q3 2020 | $9,000 | +80.0% | 37 | +164.3% | 0.00% | – |
| Q2 2020 | $5,000 | -16.7% | 14 | -83.5% | 0.00% | – |
| Q1 2020 | $6,000 | -25.0% | 85 | +19.7% | 0.00% | – |
| Q4 2019 | $8,000 | +700.0% | 71 | +373.3% | 0.00% | – |
| Q3 2019 | $1,000 | – | 15 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GROUP ONE TRADING, L.P. | 48,800 | $105,000 | 0.00% |
| SIMPLEX TRADING, LLC | 123 | $26,000 | 0.00% |